Bulletin
Investor Alert

New York Markets After Hours

Anthem Inc.

NYS: ANTM

GO
/marketstate/country/us

After Hours

 --Real time quotes

Dec 2, 2020, 4:41 p.m.

/zigman2/quotes/203808743/composite

$

318.45

Change

0.00 0.00%

Volume

Volume 14,912

Real time quotes

/zigman2/quotes/203808743/composite

Today's close

$ 313.90

$ 318.45

Change

+4.55 +1.45%

Day low

Day high

$313.07

$321.64

Open

52 week low

52 week high

$171.03

$338.20

Open

Insider Actions for Anthem Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
300   Disposition at $337 per share. 101,100
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
675   Disposition at $335.92 per share. 226,746
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,193   Disposition at $334.87 per share. 399,499
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,200   Disposition at $333.97 per share. 400,764
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,056   Disposition at $332.86 per share. 351,500
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
400   Disposition at $331.92 per share. 132,768
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
1,010   Disposition at $330.77 per share. 334,077
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
927   Derivative/Non-derivative trans. at $146.93 per share. 136,204
11/16/2020 Peter D. Haytaian
EVP & President, Commercial
781   Derivative/Non-derivative trans. at $100.77 per share. 78,701
11/09/2020 Ronald William Penczek
SVP, Chief Accounting Officer
1,199   Disposition at $330.75 per share. 396,569
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
1,893   Disposition at $292.32 per share. 553,361
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
2,500   Disposition at $292.35 per share. 730,875
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
2   Disposition at $292.64 per share. 585
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
4,780   Disposition at $292.07 per share. 1,396,094
11/03/2020 Thomas C. Zielinski
EVP & General Counsel
1,893   Derivative/Non-derivative trans. at $232.04 per share. 439,251
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,167   Disposition at $295 per share. 344,265
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
147   Disposition at $293.98 per share. 43,215
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,120   Disposition at $293.33 per share. 328,529
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,600   Disposition at $292.13 per share. 467,408
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
800   Disposition at $290.3 per share. 232,240
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
1,000   Disposition at $287.58 per share. 287,580
10/15/2020 Peter D. Haytaian
EVP & President, Commercial
4,667   Derivative/Non-derivative trans. at $100.77 per share. 470,293
10/09/2020 Peter D. Haytaian
EVP & President, Commercial
1,167   Disposition at $295 per share. 344,265
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
4,667   Disposition at $280 per share. 1,306,760
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
2,592   Derivative/Non-derivative trans. at $100.77 per share. 261,195
10/02/2020 Peter D. Haytaian
EVP & President, Commercial
2,075   Derivative/Non-derivative trans. at $89.44 per share. 185,588
10/01/2020 Jeffrey D. Alter
EVP, IngenioRx & Anthem Health
2,746   Award at $0 per share. 0
09/04/2020 Prakash R. Patel
EVP & President, DBG
118   Derivative/Non-derivative trans. at $276.22 per share. 32,593
07/02/2020 Felicia Farr Norwood
EVP & President, GBD
231   Derivative/Non-derivative trans. at $267 per share. 61,677
06/08/2020 Peter D. Haytaian
EVP & President, Commercial
14,001   Disposition at $300 per share. 4,200,300
06/08/2020 Thomas C. Zielinski
EVP & General Counsel
6,358   Disposition at $297.7 per share. 1,892,776
06/08/2020 Ramiro G. Peru
Director
1,102   Disposition at $300 per share. 330,600
06/08/2020 Ronald William Penczek
SVP, Chief Accounting Officer
545   Disposition at $297.74 per share. 162,268
06/08/2020 Peter D. Haytaian
EVP & President, Commercial
9,334   Derivative/Non-derivative trans. at $89.44 per share. 834,832
06/08/2020 Peter D. Haytaian
EVP & President, Commercial
2,087   Derivative/Non-derivative trans. at $100.77 per share. 210,306

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
7 Purchases
21 Sales
15,681
27,994
Last 6 months
9 Purchases
26 Sales
27,102
50,231
Last 12 months
45 Purchases
52 Sales
306,810
200,632

Officers and Executives

Ms. Gail Koziara Boudreaux
President, Chief Executive Officer & Director
Mr. John E. Gallina
Chief Financial Officer & Executive Vice President
Ms. Gloria M. McCarthy
Chief Administrative Officer & Executive VP
Ms. Dorothy A. Coleman
Senior VP & CFO-Government Business Division
Dr. Elizabeth Kwo
Vice President-Clinical Data Analytics
Mr. Stephen J. Schlegel
Vice President-Corporate Development
Mr. Jeffrey D. Alter
Executive VP-IngenioRx & Anthem Health Solutions
Mr. Peter D. Haytaian
EVP & President-Government Business Division
Ms. Felicia Farr Norwood
EVP & President-Government Business Division
Mr. Bill Beck
Chief Marketing Officer
Mr. Ronald William Penczek
Chief Accounting Officer & Senior Vice President
Mr. Chris Rigg
Vice President-Investor Relations
Ms. Leah S. Stark
Chief Human Resources Officer & Executive VP
Ms. Kathleen S. Kiefer
Secretary
Mr. Blair W. Todt
Chief Legal Officer & Executive Vice President
Mr. Thomas C. Zielinski
Executive Vice President & General Counsel
Ms. Elizabeth E. Tallett
Independent Chairman
Dr. Ryan M. Schneider
Independent Director
Mr. Ramiro G. Peru
Independent Director
Ms. Julie Anne Hill
Independent Director
Mr. Robert L. Dixon
Independent Director
Mr. Lewis Hay
Independent Director
Mr. R. Kerry Clark
Independent Director
Mr. Antonio Fabio Neri
Independent Director
Dr. Bahija Jallal
Independent Director
Link to MarketWatch's Slice.